An in-depth look at how the hCG market is growing, its projected size, and what’s driving demand globally.

The Human Chorionic Gonadotropin (hCG) Market is witnessing steady expansion due to growing infertility rates, expanded usage in diagnostic applications, and increasing adoption of assisted reproductive technologies (ART). hCG is widely used to induce ovulation, support luteal phase in fertility treatments, and in pregnancy testing. With more couples seeking fertility solutions globally, demand for reliable hCG products is growing.

Market size estimates place it at about USD 2.15-2.22 billion in 2024-2025, with forecasts pointing toward USD 2.94-3.0 billion by 2034, growing at a CAGR around 3.1-3.2%. Growth is underpinned by the increasing prevalence of female infertility, growing awareness of male hypogonadism, and more clinics offering fertility treatments.

The Human Chorionic Gonadotropin Market size & forecast suggests that recombinant hCG technology, home pregnancy tests, and easier regulatory access will further fuel this growth. As manufacturing improves and economies of scale increase, cost reductions may make hCG treatments and diagnostics more accessible in emerging markets.

FAQs
Q1: What is the current market value of the hCG market?
A: Around USD 2.15-2.22 billion (2024-2025).

Q2: What is the expected market in 2034?
A: About USD 2.94-3.0 billion.

Q3: What are key growth drivers?
A: Rising infertility, ART expansion, recombinant technology, and diagnostic usage.